Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L34 pseudogene 26 (RPL34P26)
- Target
- RPL34P26
- Molecular classification
- Other (Pseudogene; not classified among functional proteins like enzymes or receptors)
01
Overview
RPL34P26 (Ribosomal protein L34 pseudogene 26) is a processed pseudogene found in the human genome, classified as a non-protein coding gene. Unlike ribosomal protein genes, pseudogenes like RPL34P26 do not produce functional proteins and have no direct biological, pharmacological, or therapeutic relevance. Processed pseudogenes arise from the duplication and retrotransposition of functional genes but usually lack regulatory sequences for expression and do not contribute to ribosome assembly or function[5].
- Other names
- RPL34P26RPL34_12_1312RPL34P26 (common database abbreviation)
02
Mechanism of action
None (There is no mechanism of action, as no drugs act upon this pseudogene)
03
Biological functions
None (No known biological function; does not encode a functional protein)
04
Disease associations
None directly associated; as a pseudogene, it does not have direct involvement in diseases as a functional target
05
Safety considerations
None relevant (Not a druggable target; not associated with therapeutic intervention)
06
Interacting drugs
None (No drugs interact with this pseudogene, as it does not produce a functional protein)
07
Biomarkers
None (Not validated or recognized as a biomarker for patient selection or disease monitoring)
Beyond the preview
Go deeper on Ribosomal protein L34 pseudogene 26 (RPL34P26).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L34 pseudogene 26 (RPL34P26).